Active TB · HIV‐positive children not taking ART
Isoniazid prophylaxis may leads to lower active TB compared with placebo (low certainty).
1 finding from 1 review
Death · HIV‐positive children not taking ART
Isoniazid prophylaxis may leads to lower death compared with placebo (low certainty).
1 finding from 1 review
Active TB · Children living with HIV receiving ART
It is very uncertain whether isoniazid prophylaxis changes active TB compared with placebo (very low certainty).
1 finding from 1 review
Death · Children living with HIV receiving ART
It is very uncertain whether isoniazid prophylaxis changes death compared with placebo (very low certainty).
1 finding from 1 review
Intervention not reported
Incidence of pulmonary tuberculosis in children with HIV infection ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of pulmonary tuberculosis in children with HIV infection ‐… (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality in children with HIV infection ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in mortality in children with HIV infection ‐ isoniazid prophylaxis only (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of adverse events ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of adverse events ‐ isoniazid prophylaxis only (moderate certainty).
1 finding from 1 review
Tuberculosis · kidney transplant recipients
Isoniazid probably leads to lower tuberculosis compared with no treatment (moderate certainty).
1 finding from 1 review
INH hepatotoxicity Jaundice, elevated bilirubin, elevated liver enzymes · kidney transplant recipients
Isoniazid probably leads to higher INH hepatotoxicity Jaundice, elevated bilirubin, elevated liver… compared with no treatment (moderate certainty).
1 finding from 1 review
All‐cause mortality · kidney transplant recipients
Isoniazid showed no clear difference in all‐cause mortality compared with no treatment (low certainty).
1 finding from 1 review